But interest is growing in their effects beyond metabolismparticularly their potential influence on the brain and risk of dementia
.78 2.4, 2~3 .78 2 (T2DM) .79,80 T2DM .81 , .84,85 .86,87,88 2010 FDA T2DM Victoza .83,89,90,91,92 Saxenda .62 34 (GLP-1(7-37)) , 26 16
Who It Suits Practitioners recommend this injection for patients experiencing: Primary or secondary L-Carnitine deficiency Reduced exercise tolerance or muscle fatigue Interest in supporting fat metabolism as part of a broader wellness or body contouring plan Increased metabolic demands from athletic training or physical activity Indications This product is used to address primary and secondary carnitine deficiency, and is also associated with supporting patients with angina
Pancreas: glucose-dependent insulin, glucagon, and supports -cell function/survival
The mean changes from baseline to Week 26 for fasting serum glucose were -41 mg/dL, -36 mg/dL, -20 mg/dL, and -46 mg/dL, and for body weight were -2.0 kg, -2.0 kg, -0.8 kg, and +1.5 kg for BYDUREON, metformin, sitagliptin, and pioglitazone, respectively